Wisconsin Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,850
Closed -$985K 55
2021
Q4
$985K Sell
9,850
-15,096
-61% -$1.56M 0.41% 41
2021
Q3
$3.12M Buy
24,946
+2,600
+12% +$309K 1.28% 28
2021
Q2
$2.77M Sell
22,346
-600
-3% -$80.7K 1.09% 32
2021
Q1
$3.5M Buy
22,946
+1,246
+6% +$188K 1.45% 30
2020
Q4
$2.8M Buy
21,700
+7,500
+53% +$863K 1.08% 31
2020
Q3
$1.59M Buy
14,200
+4,700
+49% +$430K 0.73% 35
2020
Q2
$771K Sell
9,500
-25,640
-73% -$2.07M 0.39% 39
2020
Q1
$2.45M Buy
35,140
+10,220
+41% +$784K 1.6% 23
2019
Q4
$1.95M Sell
24,920
-1,100
-4% -$79.3K 0.95% 34
2019
Q3
$1.66M Buy
26,020
+4,000
+18% +$352K 0.88% 38
2019
Q2
$1.9M Buy
22,020
+20
+0.1% +$1.53K 1.02% 38
2019
Q1
$1.69M Buy
+22,000
New +$1.22M 1.5% 33

Other funds holding GH

Wisconsin Capital Management's GH Position: Q1 2022 in Review

Wisconsin Capital Management sold out of Guardant Health (GH) in Q1 2022, closing a stake of 9,850 shares — an estimated $985K sold.

Wisconsin Capital Management first reported a position in GH in Q1 2019 and held it in 12 quarters. The position peaked at $3.5M in Q1 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Wisconsin Capital Management reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Wisconsin Capital Management sold 9,850 Guardant Health shares in Q1 2022, an estimated $985K.
  • Wisconsin Capital Management first reported a position in Guardant Health in Q1 2019 and held it in 12 quarters.
  • Wisconsin Capital Management's Guardant Health position peaked at $3.5M in Q1 2021.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Wisconsin Capital Management's 13F filing for Q1 2022, filed 12 May 2022.